Theranostic Potential of

Nat Lenzo, Kenneth O'Byrne, Stanley Ngai, Laurence Krieger, Veronica Wong, David N Cade

Abstract read

In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nat LenzoGenesisCare, Alexandria, NSW 2015, Australia.ORCID 0000-0003-4882-8766

Kenneth O'ByrneMedical Oncology, Princess Alexandra Hospital, Translational Research Institute, Queensland University of Technology, Woolloongabba, QLD 4102, Australia.

Stanley NgaiMedical Oncology, Princess Alexandra Hospital, Translational Research Institute, Queensland University of Technology, Woolloongabba, QLD 4102, Australia.

Laurence KriegerGenesisCare, St Leonards (North Shore Health Hub), St Leonards, NSW 2065, Australia.

Veronica WongNepean Blue Mountains Local Health District Hospital, Penrith, NSW 2750, Australia.

David N CadeTelix Pharmaceuticals, North Melbourne, VIC 3051, Australia.

Funding

Telix Pharmaceuticals N/A

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibody–drug conjugatemCRPCmolecular imagingprecision oncologyprostate cancerPSMAradiotheranosticstargeted radionuclide therapytherapy

Identifiers

PMID42512394

DOI10.3390/cancers18142331

PMCPMC13406498

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.